PTJ
HAE icon

Paul Tudor Jones’s Haemonetics HAE Stock Holding History

Paul Tudor Jones’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,500
Closed -$842K – 3899
2025
Q4 		$842K Buy
+10,500
New +$705K ﹤0.01% 2389
2025
Q2 		– Sell
-8,000
Closed -$508K – 3447
2025
Q1 		$508K Buy
+8,000
New +$544K ﹤0.01% 2274

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Paul Tudor Jones's HAE Position: Q1 2026 in Review

Paul Tudor Jones sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 45,776 shares — an estimated $3.67M sold.

Paul Tudor Jones first reported a position in HAE in Q2 2013 and held it in 22 quarters. The position peaked at $3.67M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Paul Tudor Jones reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 45,776 Haemonetics shares in Q1 2026, an estimated $3.67M.
  • Paul Tudor Jones first reported a position in Haemonetics in Q2 2013 and held it in 22 quarters.
  • Paul Tudor Jones's Haemonetics position peaked at $3.67M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.